Exact Mass: 1142.3097

Exact Mass Matches: 1142.3097

Found 12 metabolites which its exact mass value is equals to given mass value 1142.3097, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Vancomycin aglycon

Vancomycin EP Impurity C

C53H52Cl2N8O17 (1142.2827)


   

Cholecystokinin octapeptide

3-Amino-3-{[1-({1-[({[1-({1-[(2-carboxy-1-{[1-(C-hydroxycarbonimidoyl)-2-phenylethyl]-C-hydroxycarbonimidoyl}ethyl)-C-hydroxycarbonimidoyl]-3-(methylsulphanyl)propyl}-C-hydroxycarbonimidoyl)-2-(1H-indol-3-yl)ethyl]-C-hydroxycarbonimidoyl}methyl)-C-hydroxycarbonimidoyl]-3-(methylsulphanyl)propyl}-C-hydroxycarbonimidoyl)-2-[4-(sulphooxy)phenyl]ethyl]-C-hydroxycarbonimidoyl}propanoic acid

C49H62N10O16S3 (1142.3507)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

Tenapanor

N-[2-(2-{2-[3-(6,8-dichloro-2-methyl-1,2,3,4-tetrahydroisoquinolin-4-yl)benzenesulphonamido]ethoxy}ethoxy)ethyl]-n-(4-{n-[2-(2-{2-[3-(6,8-dichloro-2-methyl-1,2,3,4-tetrahydroisoquinolin-4-yl)benzenesulphonamido]ethoxy}ethoxy)ethyl]-(C-hydroxycarbonimidoyl)amino}butyl)carbamimidic acid

C50H66Cl4N8O10S2 (1142.3097)


   

sincalide

Cholecystokinin Octapeptide (sulfated) ammonium salt

C49H62N10O16S3 (1142.3507)


V - Various > V04 - Diagnostic agents > V04C - Other diagnostic agents > V04CC - Tests for bile duct patency D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones Sincalide (Cholecystokinin octapeptide, CCK‐8) is a rapid-acting amino acid polypeptide hormone analogue of cholecystokinin (CCK) for intravenous use in postevacuation cholecystography. CCK‐8 is a major bioactive segment of CCK that retains most of the biological activities of CCK. CCK‐8 can promote gallbladder contraction by injection and helps diagnose gallbladder and pancreas disorders. CCK‐8 can increase bile secretion, cause the gallbladder to contract and relax the sphincter of Oddi, resulting in bile drainage into the duodenum. CCK‐8 is a major bioactive segment of CCK that retains most of the biological activities of CCK[1][2][3].

   

Tenapanor

Tenapanor

C50H66Cl4N8O10S2 (1142.3097)


A - Alimentary tract and metabolism > A06 - Drugs for constipation > A06A - Drugs for constipation C78276 - Agent Affecting Digestive System or Metabolism

   

N,N-(10,17-dioxo-3,6,21,24-tetraoxa-9,11,16,18-tetraazahexacosane-1,26-diyl)bis(3-(6,8-dichloro-2-methyl-1,2,3,4-tetrahydroisoquinolin-4-yl)benzenesulfonamide)

N,N-(10,17-dioxo-3,6,21,24-tetraoxa-9,11,16,18-tetraazahexacosane-1,26-diyl)bis(3-(6,8-dichloro-2-methyl-1,2,3,4-tetrahydroisoquinolin-4-yl)benzenesulfonamide)

C50H66Cl4N8O10S2 (1142.3097)


   

(2R,18R,22S,28R)-22-(2-amino-2-oxoethyl)-5,15-dichloro-2,18,32,35,37,48-hexahydroxy-19-[[(2R)-4-methyl-2-(methylazaniumyl)pentanoyl]amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentazaoctacyclo[26.14.2.23,6.214,17.18,12.129,33.010,25.034,39]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34(39),35,37,46,49-pentadecaene-40-carboxylate

(2R,18R,22S,28R)-22-(2-amino-2-oxoethyl)-5,15-dichloro-2,18,32,35,37,48-hexahydroxy-19-[[(2R)-4-methyl-2-(methylazaniumyl)pentanoyl]amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentazaoctacyclo[26.14.2.23,6.214,17.18,12.129,33.010,25.034,39]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34(39),35,37,46,49-pentadecaene-40-carboxylate

C53H52Cl2N8O17 (1142.2827)


   

(2R,18R,22S,28R)-22-(2-amino-2-oxoethyl)-5,15-dichloro-2,18,32,35,37,48-hexahydroxy-19-[[(2R)-4-methyl-2-(methylamino)pentanoyl]amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentazaoctacyclo[26.14.2.23,6.214,17.18,12.129,33.010,25.034,39]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34(39),35,37,46,49-pentadecaene-40-carboxylic acid

(2R,18R,22S,28R)-22-(2-amino-2-oxoethyl)-5,15-dichloro-2,18,32,35,37,48-hexahydroxy-19-[[(2R)-4-methyl-2-(methylamino)pentanoyl]amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentazaoctacyclo[26.14.2.23,6.214,17.18,12.129,33.010,25.034,39]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34(39),35,37,46,49-pentadecaene-40-carboxylic acid

C53H52Cl2N8O17 (1142.2827)


   

(1S,2R,18R,19R,22S,25R,28R,40S)-22-(2-amino-2-oxoethyl)-5,15-dichloro-2,18,32,35,37,48-hexahydroxy-19-[[(2R)-4-methyl-2-(methylazaniumyl)pentanoyl]amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentazaoctacyclo[26.14.2.23,6.214,17.18,12.129,33.010,25.034,39]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34(39),35,37,46,49-pentadecaene-40-carboxylate

(1S,2R,18R,19R,22S,25R,28R,40S)-22-(2-amino-2-oxoethyl)-5,15-dichloro-2,18,32,35,37,48-hexahydroxy-19-[[(2R)-4-methyl-2-(methylazaniumyl)pentanoyl]amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentazaoctacyclo[26.14.2.23,6.214,17.18,12.129,33.010,25.034,39]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34(39),35,37,46,49-pentadecaene-40-carboxylate

C53H52Cl2N8O17 (1142.2827)


   

1-Hexadecanosulfonyl-O-L-Serine-CoA; (Acyl-CoA); [M+H]+

1-Hexadecanosulfonyl-O-L-Serine-CoA; (Acyl-CoA); [M+H]+

C40H73N8O20P3S2 (1142.3595)


   

vancomycin aglycone

vancomycin aglycone

C53H52Cl2N8O17 (1142.2827)


A peptide antibiotic that is vancomycin lacking the disaccharide moiety.

   

vancomycin aglycone zwitterion

vancomycin aglycone zwitterion

C53H52Cl2N8O17 (1142.2827)


A peptide zwitterion obtained by transfer of a proton from the carboxy to the amino group of vancomycin aglycone.